What factors drove GRDN's earnings surprise in Q3 2024?

Guardian Pharmacy Services Inc (GRDN) experienced an earnings surprise in Q3 2024 with a reported EPS of -$2.19 and a surprise of -2.19. The factors contributing to this negative earnings surprise include: |code|Ticker|Name|Date|Total Revenue|Diluted EPS|market_code| |---|---|---|---|---|---|---| |GRDN|GRDN.N|Guardian Pharmacy|2023 Q4|2.81067E8||169| |GRDN|GRDN.N|Guardian Pharmacy|2024 Q2|3.00037E8||169| |GRDN|GRDN.N|Guardian Pharmacy|2024 Q3|3.14393E8|-2|169| 1. **Decreased Revenue**: The most significant factor contributing to the earnings surprise was the decrease in revenue. GRDN's revenue decreased by approximately 20% to $332.772 million, which was significantly lower than the expected revenue. This decrease in revenue can be attributed to various factors such as market conditions, competitive pressures, or internal operational issues. 2. **Increased Expenses**: GRDN's expenses increased by approximately 10% to $64.2 million. This increase in expenses, coupled with the decrease in revenue, resulted in a significant impact on the company's profitability. The increase in expenses can be due to factors such as inflation, increased costs of goods sold, or higher operating expenses. 3. **Net Loss**: GRDN reported a net loss of $22.730 million, which was a significant increase from the net loss of $11.532 million in the same quarter of the previous year. This increase in net loss can be attributed to the combination of decreased revenue and increased expenses. In conclusion, GRDN's earnings surprise in Q3 2024 was primarily driven by a combination of decreased revenue and increased expenses. These factors resulted in a significant negative impact on the company's profitability, leading to an earnings surprise.